0.04%| Prev Close: | 3.28 |
|---|---|
| Open: | 3.23 |
| Bid: | 3.32 x 1500 |
| Ask: | 3.33 x 2100 |
| 1y Target Est: | 6.33 |
| Beta: | 1.4 |
| Next Earnings Date: | N/A |
| Day's Range: | 3.22 - 3.33 |
|---|---|
| 52wk Range: | 2.11 - 3.76 |
| Volume: | 267,372 |
| Avg Vol (3m): | 454,360 |
| Market Cap: | 275.04M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.16 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Biotech Stock Mailbag: Amarin, MannKind, Palatinat TheStreet(Fri 7:00AM EDT)
- Commit To Purchase Immunomedics At $2, Earn 22.8% Annualizedat TheStreet(Thu, May 23)
- IMMUNOMEDICS INC FinancialsEDGAR Online Financials(Tue, May 14)
- 3 Health Care Stocks Under $10 to Watchat TheStreet(Thu, May 9)
- Immunomedics' CEO Discusses F3Q13 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program DevelopmentsGlobeNewswire(Wed, May 8)
- Immunomedics Earnings: Your Sneak Peek to the Big Announcementat Wall St. Cheat Sheet(Wed, May 8)
- In Danish Laboratories, Hope Looms Large for a Permanent HIV Cureat Minyanville(Wed, May 8)
- IMMUNOMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Wed, May 8)
- Q3 2013 Immunomedics Earnings Release - After Market CloseCCBN(Wed, May 8)
- Immunomedics Announces Three New Patent AwardsGlobeNewswire(Tue, May 7)
- Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial ResultsGlobeNewswire(Thu, Apr 25)
- Tackling Cancer: Non-Hodgkin Lymphoma's Biggest Current & Upcoming Playersat Motley Fool(Wed, Apr 17)
- Three Biotech Stocks With Low Price But Great Potentialat Seeking Alpha(Tue, Apr 16)
- Immunomedics develops T-Cell for tumor treatmentat theflyonthewall.com(Wed, Apr 10)
Press Releases
- Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program DevelopmentsGlobeNewswire(Wed, May 8)
- Immunomedics Announces Three New Patent AwardsGlobeNewswire(Tue, May 7)
- Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial ResultsGlobeNewswire(Thu, Apr 25)
Reports
- IMMU: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 24)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 24)
- IMMUNOMEDICS INC (IMMU) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)